Walleye Capital’s SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o SCPE.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-31,018
Closed -$341 1631
2021
Q1
$341 Sell
31,018
-116,482
-79% -$1.32M 0.02% 714
2020
Q4
$1.62K Sell
147,500
-500
-0.3% -$5.36K 0.11% 161
2020
Q3
$1.57M Hold
148,000
0.17% 158
2020
Q2
$1.54M Hold
148,000
0.34% 88
2020
Q1
$1.52M Sell
148,000
-1,900
-1% -$19.7K 0.33% 78
2019
Q4
$1.55M Sell
149,900
-100
-0.1% -$1.04K 0.1% 276
2019
Q3
$1.55M Buy
+150,000
New +$1.54M 0.09% 297

Other funds holding SCPE.U

Walleye Capital's SCPE.U Position: Q2 2021 in Review

Walleye Capital sold out of SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o (SCPE.U) in Q2 2021, closing a stake of 31,018 shares — an estimated $341 sold.

Walleye Capital first reported a position in SCPE.U in Q3 2019 and held it in 7 quarters. The position peaked at $1.57M in Q3 2020. 3 funds tracked by Wall St. Rank hold SCPE.U as of Q2 2021.

  • Walleye Capital reported no remaining SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o position as of Q2 2021 after selling out during the quarter.
  • Walleye Capital sold 31,018 SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o shares in Q2 2021, an estimated $341.
  • Walleye Capital first reported a position in SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o in Q3 2019 and held it in 7 quarters.
  • Walleye Capital's SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o position peaked at $1.57M in Q3 2020.
  • 3 funds tracked by Wall St. Rank held SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.